Home › GLP-1 Medications › Eli Lilly
Latest four-week snapshot through 2026-08-05 · 1 wave. Use the controls above to change the window.
GLP-1 Medications · 1 wave · n=72 answers, pooled
How often each assistant brings the brand up in recommendation answers.
| assistant | share of voice | answers |
|---|---|---|
| ChatGPT | 96% | 23 of 24 |
| Claude | 100% | 24 of 24 |
| Gemini | 67% | 16 of 24 |
Wave-by-wave share of recommendation answers that named this brand.
| wave | share of voice | answers | change |
|---|---|---|---|
| 2026-08-05 | 88% | 63 of 72 |
Recurring descriptions in the assistants' own words, grouped by theme.
“If you are looking to lose weight, **Zepbound (tirzepatide)** is the superior choice by a wide margin.”
“They are administered as a weekly injection, have the same side effects, and come in the exact same doses (ranging from 2.”
“Rybelsus is a daily oral tablet, whereas Mounjaro is a once-weekly subcutaneous injection.”
“* **Your primary goals are maximum weight loss and superior blood sugar control:** Mounjaro is a dual-action medication (targeting both GIP and GLP-1 receptors), making it highly effective.”
“* **FDA Approval:** Zepbound is specifically FDA-approved for chronic weight management (for adults with obesity, or those who are overweight with at least one weight-related condition).”
“If you **do not** have Type 2 diabetes, insurance will almost certainly deny coverage for Mounjaro. You will have to pay the full out-of-pocket retail price (often upwards of $1,000/month).”
“Because they are FDA-approved for entirely different medical conditions, choosing the wrong one could mean your insurance won't cover it or you won't get the specific health benefits you need.”
“medications like Wegovy (semaglutide) and Zepbound (tirzepatide) are also expensive brand-name drugs, they are weekly injections (rather than daily, like Saxenda) and are clinically shown to produce greater weight loss. If you have commercial insurance, manufacturers offer saving”
“If you do not have Type 2 diabetes and your goal is chronic weight management, **Zepbound** is the correct choice.”
“If you are eligible for either and the deciding goal is **the greatest average weight loss**, choose Zepbound (tirzepatide).”
589 exact quoted mentions in this snapshot, grouped by coded tone.
“tirzepatide (Mounjaro/Zepbound) tends to show greater average weight loss in trials than semaglutide”
“**Zepbound** (tirzepatide) – weekly injection, dual GLP-1/GIP agonist”
“**Zepbound** – approved for weight management (dual GLP-1/GIP agonist)”
“**Zepbound** (tirzepatide) – weekly injection; dual GLP-1/GIP agonist, often shows greater average weight loss than semaglutide in trials”
“tirzepatide-based drugs (Mounjaro/Zepbound) have shown greater average weight loss in trials than semaglutide-based ones”
“**Trulicity** – for type 2 diabetes”
“**Mounjaro** (tirzepatide)”
“**Mounjaro** – approved for type 2 diabetes, sometimes used off-label for weight loss”
“**Tirzepatide** – sold as Mounjaro (diabetes) and Zepbound (weight loss); a dual GLP-1/GIP agonist”
“**Dulaglutide** – sold as Trulicity (diabetes)”
“Novo Nordisk is currently suing Eli Lilly over Zepbound ads. The ads compare Lilly's Zepbound with Novo's Wegovy, and Novo argues they give consumers a misleading picture of how the drugs compare”
“these were discontinued by AstraZeneca in October 2024”
“Byetta and Bydureon (exenatide) were discontinued by the manufacturer in October 2024”
“Novo Nordisk filed a lawsuit against Eli Lilly, accusing it of false advertising.”
“The dispute centers on dosing comparisons: Eli Lilly says its ads are based on the SURMOUNT-5 trial, completed in 2024, which compared patients on 10 or 15 milligrams of Zepbound to patients on 1.7 mg or 2.4 mg doses of Wegovy.”
Which competitors assistants suggest when shoppers ask for something cheaper.
89 of 590 mentions appear alongside an identifiable web citation. Citation does not establish causation.
| cited source | mentions |
|---|---|
| noom.com | 8 |
| goodrx.com | 8 |
| formblends.com | 7 |
| drugs.com | 6 |
| injectco.com | 6 |
| singlecare.com | 6 |
| doctronic.ai | 5 |
| fda.gov | 5 |
| pandameds.com | 5 |
| sesamecare.com | 5 |
| preventionclinics.com | 4 |
| weightwatchers.com | 4 |
Stores and sites assistants name as places to buy this brand.
| retailer | mentions |
|---|---|
| LillyDirect | 35 |
| Costco | 3 |
| Kroger | 1 |
| Walmart | 1 |
| GoodRx | 1 |
| SingleCare | 1 |
| participating pharmacies | 1 |
| Sesame | 1 |
Method: fixed shopper questions asked repeatedly to Claude, OpenAI GPT and Gemini with web search on. Shares are the percentage of recommendation answers mentioning the brand. Quotes are AI outputs; full transcripts are kept as receipts.